US FDA Must Assess Business Impact Of Final Interstate Compounding MOU, Court Rules

 
• By Bowman Cox
  
Compounding pharmacy
an 'inordinate' delay on interstate compounding • Source: Alamy

More from Distribution/Supply Chain

More from Compliance